Dexon Biotech Private Limited
About Dexon Biotech Private Limited
Data last updated:
Dexon Biotech Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24110HR2016PTC066268. Its GSTIN is 06AAFCD9379K1Z1 (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anmol Garg and Vivek Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101/2 Ground Floor Rani Bagh Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.87 Cr, a growth of 96% compared to the previous year. For the same year it recorded a net profit of ₹1.68 Lakh (net margin 0.9%) and EBITDA of ₹4.13 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 59% over three years and 44% over five years.
The company is associated with 1 brand: Dexon Biotech. Court records list 10 cases involving the company, including 10 filed by the company; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address101/2 Ground Floor Rani Bagh Ambala Cantt, Haryana, India – 133001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dexon Biotech Private Limited
The main business activity of Dexon Biotech is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dexon Biotech Private Limited FY 2025 filings available
Dexon Biotech Private Limited reported revenue of ₹1.87 Cr (up 96% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dexon Biotech Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 96% growth in the latest year. EBITDA rose 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dexon Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.13 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.68 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dexon Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dexon Biotech are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dexon Biotech Private Limited
Dexon Biotech Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sri Kannan Ventures Private Limited | ₹1.87 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Chennai, Tamil Nadu, India |
| Pashupati Chemicals & Pharmaceuticals Limited | ₹1.87 Cr (FY 2024) | •••• | •••• | -23.0% | •••• | Kolkata, West Bengal, India |
| Sree Bhavani Commercial Enterprises Pvt Ltd | ₹1.87 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | Thiruvananthapuram, Kerala, India |
| Agile Trading and Investment Private Limited | ₹1.87 Cr (FY 2017) | •••• | •••• | -63.0% | •••• | Mumbai, Maharashtra, India |
| Linkline Agencies Private Limited | ₹1.87 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Kolkata, West Bengal, India |
| Dexon Biotech Private Limited this company | ₹1.87 Cr (FY 2025) | •••• | •••• | 96.0% | •••• | Ambala Cantt, Haryana, India |
| Kedy Mart Private Limited | ₹1.87 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | New Delhi, Delhi, India |
| Rajdarbar Marketing Private Limited | ₹1.87 Cr (FY 2017) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Benz Furniture Private Limited | ₹1.87 Cr (FY 2024) | •••• | •••• | -40.0% | •••• | Ahmedabad, Gujarat, India |
| Anjani Geo-Mining Industries Private Limited | ₹1.87 Cr (FY 2025) | •••• | •••• | -99.0% | •••• | Raipur, Chhattisgarh, India |
| Improve Marketing Private Limited | ₹1.87 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Dexon Biotech by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dexon Biotech Private Limited
Dexon Biotech Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIKAS SANJIV & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dexon Biotech Private Limited
Dexon Biotech has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anmol Garg | Director | 10 Mar 2021 | 5 Years 7 Months | Current |
| Vivek Garg Also directs: Deksun Healthcare Private Limited | Director | 29 Nov 2021 | 4 Years 10 Months | Current |
Ownership and Shareholding of Dexon Biotech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dexon Biotech Private Limited
Dexon Biotech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Dexon Biotech Private Limited
Dexon Biotech Private Limited has 10 court cases on record: 10 filed by Dexon Biotech. 2 cases are pending and 8 are disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 0 | 2 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against Krishna Pharma | Disposed |
| District court, Ambala, Haryana | Commercial suit | Filed by the company against Chemicare Pharmaceuticals | Disposed |
| District court, Ambala, Haryana | Commercial suit | Filed by the company against an individual | Disposed |
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Dexon Biotech Private Limited
Dexon Biotech operates one associated brand: Dexon Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical products and offers franchise for distribution. | dexonbiotech.com |
Employees and EPFO Compliance at Dexon Biotech Private Limited
Employment history and EPFO contributions of people linked to Dexon Biotech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dexon Biotech Private Limited
Dexon Biotech Private Limited has 7 board changes on record since 2019: 2 appointments and 5 cessations. The latest: Surinder Pal Singh ceased to be Director on 08 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Dexon Biotech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dexon Biotech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dexon Biotech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dexon Biotech Private Limited
Dexon Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCD9379K1Z1 | Haryana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dexon Biotech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dexon Biotech Private Limited
Dexon Biotech is an active private limited company based in Ambala Cantt, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 November 2016 (10+ years old) and is registered under CIN U24110HR2016PTC066268.
Dexon Biotech reported revenue of ₹1.87 Cr for FY 2025 (up 96% YoY).
Dexon Biotech has 2 current directors:
- Anmol Garg - Director
- Vivek Garg - Director
Dexon Biotech reported a net profit of ₹1.68 Lakh (net margin 0.9%) and EBITDA of ₹4.13 Lakh (EBITDA margin 2.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dexon Biotech is 59% over three years and 44% over five years. In the latest year (FY 2025) revenue rose 96%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dexon Biotech is 06AAFCD9379K1Z1, registered in Haryana.
The CIN (Corporate Identification Number) of Dexon Biotech is U24110HR2016PTC066268. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dexon Biotech has 10 court cases on record: 10 filed by the company. 2 are pending.
Dexon Biotech was incorporated on 02 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Dexon Biotech by revenue are Sri Kannan Ventures Private Limited, Pashupati Chemicals & Pharmaceuticals Limited, Sree Bhavani Commercial Enterprises Pvt Ltd, Agile Trading and Investment Private Limited, Linkline Agencies Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Surinder Pal Singh ceased to be Director on 08 Sep 2022. Sanchit Sidana ceased to be Director on 03 Aug 2022. Anmol Garg ceased to be Additional Director on 29 Nov 2021. Dexon Biotech has 7 board changes on record in total.